Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the contract from the U.
Britain's health regulator said on Friday it has approved Moderna's vaccine to protect patients aged 60 and over against ...
We came across a bullish thesis on Moderna, Inc. (MRNA) on wallstreetbets Subreddit Page by YouAlwaysHaveAChoice. In this ...
Newsable Asianet News on MSN2h
Moderna Stock Heads For Weekly Loss As Retail Caution Prevails: Wealth Advisor Tells Why She's Staying On The SidelinesShares of Moderna Inc. (MRNA) are on track for a more than 12% weekly decline, with sentiment among retail traders turning ...
As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases ...
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...
We recently published a list of 10 Firms Kick Off Shortened Trading Week With Impressive Gains. In this article, we are going ...
Have you assessed how the international operations of Moderna (MRNA) performed in the quarter ended December 2024? For this biotechnology company, possessing an expansive global footprint ...
Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback